Skip to content

Banned pharmaceutical (anticholinergic)

Benzatropine (INN) and its salts

CAS 86-13-5
4

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

Benzatropine is a prescription anticholinergic drug used for Parkinson's disease. It is a medicine, not a cosmetic ingredient, and is banned from skincare and personal care products in the EU.

Skin benefits

  • Prescription anticholinergic medicine, no cosmetic role
  • Used medically for Parkinsonism and extrapyramidal symptoms

Known concerns

  • Pharmaceutical active substance, not a cosmetic ingredient
  • Anticholinergic systemic effects including dry mouth, blurred vision, tachycardia
  • Banned from cosmetic use under EU Annex II
  • Risk of central nervous system effects on absorption

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find Benzatropine (INN) and its salts in your products.

Scan any cosmetic product with LuxSense to see if it contains Benzatropine (INN) and its salts and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.